Results 221 to 230 of about 15,676,085 (372)
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
The POETIC (PrOcess Evaluation of Trials In Critical care) Framework: A Structured Approach for Designing and Conducting Process Evaluations in Critical Care Trials. [PDF]
Emerson LM +3 more
europepmc +1 more source
Draft area inspection framework for consultation: a supplement to the Common inspection framework [PDF]
core
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra +10 more
wiley +1 more source
Developing a Gender Framework for Responsive and Adaptive Design in Digital Health (FORWARD) from a review of reviews. [PDF]
Kalbarczyk A +6 more
europepmc +1 more source
Metal organic frameworks as a drug delivery system for flurbiprofen
Muder Al Hayder +3 more
openalex +2 more sources
Effect of chemotherapy on passenger mutations in metastatic colorectal cancer
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui +6 more
wiley +1 more source
A competency-based leadership framework for public health trainers in Meghalaya: insights from a multi-method study. [PDF]
Bumb D, Gupta P, Nooyi SC, Chaudhury N.
europepmc +1 more source

